Dr Reddy's launches Avigan tablets in India for Covid-19
Hyderabad
19-August-2020
Pharma major Dr Reddy's Laboratories Ltd on Wednesday announced the launch of Avigan (Favipiravir) 200 mg tablets for treatment of Covid-19 in India.
The launch is part of the global licensing agreement with Fujifilm Toyama Chemical Co. Ltd that grants Dr Reddy's the exclusive rights to manufacture, sell and distribute Avigan (Favipiravir) 200 mg tablets in India.
Avigan has been approved by the Drugs Controller General of India (DCGI) for the treatment of patients with mild to moderate Covid-19 disease.
"We are pleased to bring this important innovator medicine to the patients in India.AThe need for high quality and efficacy, affordability and better disease management are key priorities for us. We believe that Avigan would provide an effective treatment option to the Covid-19 impacted patients in India," said M.V. Ramana, Chief Executive Officer, Branded Markets (India and Emerging Markets), Dr Reddy's Laboratories.
Dr Reddy's Avigan comes in a complete therapy pack of 122 tablets with a two-year shelf life.
To ensure accelerated access to the medicine, Dr Reddy's has initiated a free home delivery service in 42 cities in the country, and a helpline centre at 1800-267-0810/www.readytofightcovid.in between 9 a.m. to 9 p.m. Monday to Saturday. - IANS
More Headlines
Sex Scandal: SIT Rejects Prajwal Revanna’s Request; Lookout Notice Issued, Another Victim Comes Forward
Explore Sridevi's Cherished Chennai Home with Host Janhvi Kapoor on Airbnb
Sanjay Raut Questions Increase In Maha Voting Percentage After 11 Days
Rohit Nagdewani’s Fresh From Farm Raises $2 Million, Aims For Aggressive Expansion in Delhi/ NCR
IIT Roorkee Startup Wins DRDO's 'Dare to Dream 4.0' with Innovative Gun-Shot Detection Tech
Sex Scandal: SIT Rejects Prajwal Revanna’s Request; Lookout Notice Issued, Another Victim Comes Forward
Explore Sridevi's Cherished Chennai Home with Host Janhvi Kapoor on Airbnb
Sanjay Raut Questions Increase In Maha Voting Percentage After 11 Days
Rohit Nagdewani’s Fresh From Farm Raises $2 Million, Aims For Aggressive Expansion in Delhi/ NCR
IIT Roorkee Startup Wins DRDO's 'Dare to Dream 4.0' with Innovative Gun-Shot Detection Tech